首页> 中文期刊> 《安徽医药》 >复方平地木合剂治疗糖尿病性视网膜病变眼底出血的临床观察

复方平地木合剂治疗糖尿病性视网膜病变眼底出血的临床观察

         

摘要

Objective To observe the clinical effects of Japanese ardisia compound mixture in patients with fundus hemorrhage caused by diabetic retinopathy.Methods Total one hundred and two patients were randomly divided into two groups,fifty patients in control group treated by conventional method and fifty two in therapeutic group treated with Japanese ardisia compound mixture in addition to conventional treatment.Results Compared with the control group,the difference between the total effect rate and total effective rate of the therapeutic group was statistically significant after 2 and 4 weeks (P < 0.05),and 8 weeks (P < 0.01).The difference of blood specific viscosity at both low and high shear rate,plasma viscosity,platelet adhesion rate and fibrinogen was statistically significant (P < 0.05) after 8 weeks.Conclusions Japanese ardisia compound mixture can significantly improve clinical effect for fundus hemorrhage caused by diabetic retinopathy.%目的 观察复方平地木合剂对糖尿病性视网膜病变眼底出血患者的临床疗效.方法 将102例糖尿病性视网膜病变眼底出血患者采用随机数字表法分为对照组50例与治疗组52例,对照组常规治疗,治疗组在常规治疗基础上加用复方平地木合剂.结果 治疗组与对照组比较,总有效率和总显效率在2、4、8周后差异有统计学意义(P<0.05);全血低切黏度和全血高切黏度、血浆黏度、血小板黏附率、纤维蛋白原8周后差异有统计学意义(P<0.05).结论 复方平地木合剂能显著改善糖尿病性视网膜病变眼底出血患者血液流变学的各项指标,改善临床治疗效果.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号